Dana-Farber Cancer Institute: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
The registry lists 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Dana-Farber Cancer Institute as lead sponsor. 2 are open to participants now and 6 have results posted.
Early Phase 1 1Phase 1 5Phase 2 6Phase 3 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young AdultsNot yet recruitingNCT07516353Not applicable
- ALL Backbone in AYAsRecruitingNCT07227584Phase 2
- Insomnia Prevention in Children With Acute Lymphoblastic LeukemiaCompletedNCT05866887Not applicableResults posted
- SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic LymphomaActive, not recruitingNCT01574274Phase 2Results posted
- Deferoxamine for Iron Overload Before Allogeneic Stem Cell TransplantationTerminatedNCT00658411Not applicableResults posted
- ALL Adult Consortium Trial: Adult ALL TrialCompletedNCT00476190Phase 2Results posted
- 05-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00400946Phase 3Results posted
- A Study in Adults With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00136435Phase 2Results posted
- Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLActive, not recruitingNCT03740334Phase 1
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsActive, not recruitingNCT03020030Phase 3
- Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AMLActive, not recruitingNCT02091245Phase 1
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
- Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related DisordersActive, not recruitingNCT01177527
- Observational Study of Iron Overload in Stem Cell TransplantationCompletedNCT00954720
- Rapamycin in Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00874562Phase 1
- Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory LeukemiaCompletedNCT00251368Phase 1
- Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00165178Phase 3
- Treatment of Childhood Acute Lymphoblastic LeukemiaTerminatedNCT00165087Phase 3
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
- Vaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00020670Early Phase 1